Evaluation of ascending aorta wall in rheumatoid arthritis by tissue and strain Doppler imaging during anti-tumor necrosis factor-α therapy

Clinical Cardiology

Volumn 37, Issue 12, 2014, Pages 738-743

  Vizzardi, Enrico ^a   Cavazzana, Ilaria ^a   Sciatti, Edoardo ^b   Bonadei, Ivano ^a   D'Aloia, Antonio ^a   Tincani, Angela ^b   Franceschini, Franco ^b   Metra, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; AORTA VALVE; AORTA WALL; ARTERIAL STIFFNESS; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELASTIC TISSUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RIGIDITY; TISSUE AND STRAIN DOPPLER IMAGING; TISSUE DOPPLER IMAGING; ANTAGONISTS AND INHIBITORS; AORTA; ARTHRITIS, RHEUMATOID; COMPLICATION; DRUG EFFECTS; ECHOGRAPHY; ELASTICITY; MIDDLE AGED;

AORTA; ARTHRITIS, RHEUMATOID; ECHOCARDIOGRAPHY; ELASTICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919653239     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22332     Document Type: Article

References (29)

1. Del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-2745.
2. Maki-Petaja KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by antitumor necrosis factor alpha therapy. Circulation. 2006;114:1185-1192.
3. Wong M, Toh L, Wilson A, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum. 2003;48:81-89.
4. Dixon WG, Watson KD, Lunt M, et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007;56:2905-2912.
5. Barnabe CCM, Martin BJ, Ghali WA. Effect of anti-tumor necrosis factor alpha therapy on cardiovascular events in rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Rheum. 2010;62:S128.
6. Greenberg JD, Furer V, Farkouh ME. Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol. 2011;8:13-21.
7. Jacobsson LT, Turesson C, Gulfe A, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol. 2005;32:1213-1218.
8. Jacobsson LT, Turesson C, Nilsson JA, et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:670-675.
9. Cugno M, Ingegnoli F, Gualtierotti R, et al. Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis. Curr Vasc Pharmacol. 2010;8:285-292.
10. Mäki-Petäjä KM, Elkhawad M, Cheriyan J, et al. Anti-tumor necrosis factor-therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation. 2012;126:2473-2480.
11. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
12. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
13. Kawasaki T, Sasayama S, Yagi S, et al. Non-invasive assessment of the age related changes in stiffness of major branches of human arteries. Cardiovasc Res. 1987;21:678-687.
14. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
15. Nigam A, Mitchell GF, Lambert J, et al. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92:395-399.
16. Gur M, Yilmaz R, Demirbag A, et al. Relationship between impaired elastic properties of aorta with left ventricle geometric patterns and left ventricle diastolic functions in patients with newly diagnosed essential hypertension. Int J Clin Pract. 2006;60:1357-1363.
17. Hansen TW, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664-670.
18. Mattace-Raso FUS, van der Cammen TJM, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657-663.
19. Yasmin, McEniery CM, Wallace S, et al. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969-974.
20. Klocke R, Cockcroft JR, Taylor GJ, et al. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis. 2003;62:414-418.
21. Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005;46:194-199.
22. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis: prevalence and associated factors. Ann Intern Med. 2006;144:249-256.
23. O'Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426-444.
24. Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans. Am J Hypertens. 2002;15:743-753.
25. Jatoi NA, Mahmud A, Bennett K, et al. Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques. J Hypertens. 2009;27:2186-2191.
26. Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010;31:2338-2350.
27. Angel K, Provan SA, Gulseth HL, et al. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension. 2010;55: 333-338.
28. Vizzardi E, Cavazzana I, Pezzali N, et al. Elastic properties of the ascending aorta in patients with rheumatoid arthritis. Int J Cardiol. 2011;150:368-369.
29. Roldan CA, Alomari IB, Awad K, et al. Aortic stiffness is associated with left ventricular diastolic dysfunction in systemic lupus erythematosus: a controlled transesophageal echocardiographic study. Clin Cardiol. 2014;37:83-90.